Early Diagnosis of COVID-19 in January 2020

Authors

  • Giulio Tarro T.&L. de Beaumont Bonelli Foundation for Cancer Research, Naples, Italy

DOI:

https://doi.org/10.14738/bjhr.1202.18586

Keywords:

Coronavirus, Wuhan-CoV, SARS, MERS, bat

Abstract

With reference to two books signed by Tarro a few months after the outbreak of the pandemic, “Covid 19 – The virus of fear” (June 2020) and then “Covid 19 – The nightmare is over” (June 2022), they were prophetic because, to give just two examples, in the first one, in addition to underlining the macroscopic errors of our Italian government, which acted only with ‘Tachipirina and watchful waiting’ and denying access to treatments (such as hydroxychloroquine and invermectin even though they are present, and not very expensive, in all pharmacies) legalized only in December 2022 after an order of the Council of State, it has put the spotlight on those mechanisms of fear, panic, terror used by Western governments to chloroform and enslave citizens, forced into those nefarious lockdowns (and then vaccines). In the second book, he extensively illustrated the adverse effects caused by 'Covid products', especially those with mRMA (such as Pfizer and Moderna) which, completely experimental, not very effective and even more unsafe, have caused and are causing enormous problems, in particular affecting the cardiovascular system, with increases in pericarditis, myocarditis, strokes, thrombosis and heart attacks. But there is more. In the last book Tarro proposes the adoption of ad hoc GENETIC TESTS, to verify whether the organism of a certain individual can withstand the impact of the vaccine: fundamental tests (even if expensive, and our Italian State should take care of them) but never even taken into consideration by the governments that have succeeded one another, with the health of citizens rolling towards the abyss.

References

Tarro G. The new coronavirus from the city of Wuhan. The Journal of Biologists, year III, n. 1, January 2020.

Grag S, Reinhart K, Couture A etl al. Highly Pathogenic Avian Influenza A (H5N1) Virus Infections in Humans. The New England Journal of Medicine, vol. 392, n. 9, February 27, 2025.

Ison MG and Marrazzo J. The Emerging Threat of H5N1 to Human Health. The New England Journal of Medicine, vol 329, n. 9, February 27, 2025.

Jassem AN, Roberts A, Tyson J et al. Critical Illnes in an Adolescent with Influenza A (H5N1) Virus Infection. The New England Journal of Medicine, vol 329, n. 9, February 27, 2025. 291 British Journal of Healthcare and Medical Research (BJHR)

Tarro G. The New Coronavirus from the Chinese City of Wuhan. Int J Recent Sci Res. 11(01), pp. 36901-36902, 2020. DOI: http://dx.doi.org/10.24327/ijrsr.2020.1101.5021.

Tarro G. COVID the virus of fear. Il mio libro.it. First edition May 2020 and second editon August 2020, ISBN 978-88-316-8520-7, Greek edition 2020, ISBN 978-6182-010-341.

Tarro G. Environment and Virus Interactions: Towards a Systematic Therapy of SARS-CoV-2. British Journal of Healthcare and Medical Research, 9(4), 253-260, 2022.

Tarro G. On the End of a Nightmare (COVID-19). The Role of the Immune System. British Journal of Healthcare and Medical Research, 9(6), 194-197, 2022.

Tarro G. Western Season with Epidemic Flu, SARS-CoV-2 Omicron Strains and hRSV. British Journal of Healthcare and Medical Research, 10(2), 448-453, 2023.

Elisabetta Traggiai, Stephan Becker, Antonio Lanzavecchia. An efficient method to produce human monoclonal antibodies from memory B cells demonstrated consistent neutralization of SARS corona virus. Nature Medicine 10, 871-875, 2004.

J. ter Meulen et al. Human monoclonal antibodie sa sprophylaxis for SARS coronavirus infection have been used in ferrets. The Lancet 26, 6, 2004.

Tianlei Ying, Haoyang Li, Lu Lu, Dimiter S Dimitrov, Shibo Jiang. The recent success of identifying neutralizing human antibodies (mAbs against MERS- CoV) suggests the possibility of using these methodologies for a rapid response against emerging viruses and with the potential to cause pandemics. Microbes Infect. 2015 Feb; 17(2): 142-148.

Tarro G. COVID-19 The End of a Nightmare. Edition Helicon, July 2022.

Tarro G. Different Background of Immunological Response Acoording to Previous Zoonotic Experience with Coronavirus. Internatioonal Journal of Development Research, vol. 10, issue 10, pp. 41650-41651, 2020.

Arantes de Araùjo L, Federico Veloso C, de Campos Souza M, Coelho de Azevedo JM, Tarro G. The Potential Impact of the COVID-19 Pandemic on Child Growth and Development: a Systematic Review. Jornal de Pediatria, DOI: 10.1016/ipd.2020.08.008.

Downloads

Published

2025-04-25

How to Cite

Tarro, G. (2025). Early Diagnosis of COVID-19 in January 2020. British Journal of Healthcare and Medical Research, 12(02), 288–292. https://doi.org/10.14738/bjhr.1202.18586

Most read articles by the same author(s)

<< < 1 2 3